Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

HEART CONGRESS 2026

Welcome Message

On behalf of the Organizing Committee, it is our great honor and privilege to welcome you to the 40th World Congress on Heart Diseases, to be held on April 06–07, 2026, in Paris, France. This landmark 40th edition represents four decades of scientific excellence, innovation, and global collaboration in the field of cardiovascular medicine.

The congress is designed to serve as a comprehensive platform for cardiologists, cardiac surgeons, researchers, scientists, healthcare professionals, industry experts, and policy makers to come together and exchange cutting-edge research, clinical experiences, and emerging technologies addressing heart diseases. The scientific program features keynote lectures, plenary sessions, symposia, workshops, and poster presentations covering a wide range of topics, including cardiovascular prevention, diagnostics, therapeutics, interventional cardiology, heart failure, arrhythmias, and translational research.

In an era of rapid scientific advancement and evolving healthcare challenges, this congress aims to promote interdisciplinary dialogue, encourage innovation, and inspire collaborative efforts that will shape the future of cardiovascular care and improve patient outcomes worldwide. The 40th World Congress on Heart Diseases also provides a valuable opportunity for early-career researchers and young investigators to engage with global experts and contribute to the advancement of the field.

Hosted in the beautiful and historic city of Paris, a global center of culture, science, and innovation, we hope that your participation will be both professionally rewarding and personally enriching. Beyond the scientific sessions, the congress offers ample opportunities for networking, collaboration, and the exchange of ideas in an atmosphere of collegiality and excellence.

We are delighted to welcome you to this prestigious gathering and sincerely hope that the 40th World Congress on Heart Diseases will be a memorable and impactful experience for all participants. We wish you a successful congress and an enjoyable stay in Paris.

About Heart Congress 2026

The 40th World Congress on Heart Diseases, scheduled for April 06–07, 2026, in Paris, France, is a premier international forum dedicated to advancing knowledge and innovation in cardiovascular medicine. This distinguished congress will bring together renowned keynote speakers, leading scientists, clinicians, researchers, healthcare professionals, and delegates from across the globe to discuss the latest developments in the prevention, diagnosis, and treatment of heart diseases.

The conference program includes inspiring keynote lectures, comprehensive scientific sessions, interactive discussions, and poster presentations that highlight cutting-edge research and emerging trends in cardiology. These sessions provide an excellent opportunity for knowledge exchange, professional growth, and collaboration among experts and young investigators alike.

An extensive exhibition will showcase the latest medical technologies, pharmaceutical advancements, diagnostic tools, and healthcare solutions, offering participants the chance to engage directly with industry leaders and innovators.

Beyond the scientific experience, the congress offers attendees the opportunity to explore the beauty and culture of Paris, one of the world’s most iconic cities. From historic landmarks and museums to world-class cuisine and vibrant city life, Paris provides a memorable backdrop for networking, collaboration, and cultural enrichment.

The 40th World Congress on Heart Diseases promises to be an intellectually stimulating and rewarding experience, combining high-quality science with global networking and cultural exploration.

Why Attend Heart Congress 2026?

Heart Congress 2026 serves as a premier international platform dedicated to advancing knowledge in cardiology for both the academic community and the healthcare industry. The conference promotes the dissemination of cutting-edge research and clinical insights related to the diagnosis, prevention, and management of heart diseases, while encouraging meaningful exchange of ideas among global experts.

This Heart Disease Conference is designed to deliver a dynamic and educational scientific program featuring plenary lectures, symposia, seminars on diverse cardiovascular themes, poster presentations, and interactive sessions. Participants from across the world will have the opportunity to engage with leading professionals, explore emerging trends, and contribute to discussions shaping the future of cardiovascular care.

  • Knowledge Enrichment
  • Expert Learning
  • Networking Opportunities
  • Interactive Workshops
  • Scientific Exchange
  • Multidisciplinary Insights
  • Career Development
  • Global Perspectives
  • Inspiration and Motivation
  • Exhibition Engagement
  • Certificate of Participation
  • CME and CPD Points

Target Audience

Attending to Heart Diseases

The term “attending to heart diseases” refers to the comprehensive process of observing, preventing, diagnosing, treating, and managing cardiovascular disorders. Effective heart disease care requires a collaborative approach involving individuals, healthcare professionals, and support networks working together to improve outcomes and enhance quality of life.

Key Stakeholders in Heart Disease Care

Individuals and Patients
Every individual plays a fundamental role in maintaining heart health by adopting healthy lifestyle practices, managing risk factors such as hypertension, diabetes, and obesity, and seeking timely medical evaluation and care. Active patient participation is essential for prevention, early diagnosis, and long-term disease management.

Healthcare Providers
Healthcare professionals, including physicians, cardiologists, nurses, and allied health specialists, are central to the diagnosis, treatment, and ongoing management of heart diseases. Their responsibilities include conducting clinical assessments, performing diagnostic and interventional procedures, prescribing and monitoring medications, providing evidence-based guidance, and tracking patient progress through continuous care.

Family Members and Caregivers
Family members and caregivers provide vital support to individuals living with heart conditions. Their role often includes assisting with medication adherence, encouraging healthy lifestyle changes, offering emotional support, and helping patients navigate long-term treatment and rehabilitation plans.

Target Audience

• Cardiologists and Cardiovascular Specialists
• Cardiac and Cardiothoracic Surgeons
• Interventional Cardiologists
• Researchers and Scientists in Cardiovascular Medicine
• Nurses and Allied Health Professionals
• Medical Students, Residents, and Trainees
• Healthcare Administrators and Policy Makers
• Pharmaceutical and Medical Device Industry Professionals
• Academic Institutions and Educators
• Global Health Organizations
• Medical Societies and Professional Associations

Market Analysis

The global market associated with heart diseases and cardiovascular care represents one of the largest segments within the healthcare industry due to the high disease burden worldwide. Cardiovascular diseases account for millions of deaths annually and continue to drive demand for prevention, diagnosis, and treatment solutions. The overall cardiovascular market is currently valued at approximately United States Dollars 300 billion, reflecting combined spending on pharmaceuticals, medical devices, diagnostics, and therapeutic services. Rising prevalence of hypertension, coronary artery disease, heart failure, and stroke significantly contributes to this market size.

Pharmaceuticals form a major share of the heart disease market, with cardiovascular drugs estimated to account for around United States Dollars 150 to 160 billion globally. These include therapies for blood pressure regulation, cholesterol reduction, anticoagulation, and heart failure management. In addition, the cardiovascular medical devices segment is valued at approximately United States Dollars 50 to 60 billion, driven by increasing use of stents, pacemakers, implantable defibrillators, heart valves, and advanced cardiac imaging systems. Technological innovation and growing adoption of minimally invasive and interventional cardiology procedures continue to expand this segment.

The heart disease market is projected to experience sustained growth, with estimates suggesting it could exceed United States Dollars 380 to 400 billion in value in the coming years, growing at an average annual rate of five to seven percent. Growth is supported by early disease detection, preventive cardiology programs, digital health integration, and expanding access to cardiac care in emerging economies. This strong market outlook underscores the importance of global scientific forums, such as international cardiology conferences, in fostering collaboration, innovation, and knowledge exchange to address the escalating burden of heart diseases worldwide.

Major Industries in the Heart Disease Market

  • Cerevast Therapeutics
  • Paragon Medical
  • Procyrion
  • Apaxis Medical
  • Biotronik
  • Angel Medical Systems
  • Topera Medical (Abbott)
  • Mitralign
  • Vittamed
  • TransMedics
  • AtCor Medical
  • Spectranetics
  • Miami Cardiovascular Innovations
  • Guided Delivery Systems
  • REVA Medical

Major Societies for Cardiology

Americas

  • American Association for Thoracic Surgery
  • American Association of Cardiovascular and Pulmonary Rehabilitation
  • American Association of Heart Failure Nurses
  • American College of Cardiology
  • American Heart Association
  • American Society for Preventive Cardiology
  • American Society of Echocardiography
  • American Society of Hypertension
  • American Society of Nuclear Cardiology
  • American Stroke Association
  • Canadian Cardiovascular Society
  • Canadian Association of Interventional Cardiology
  • Canadian Association of Cardiovascular Prevention and Rehabilitation
  • Argentine Society of Cardiology
  • Brazilian Society of Cardiology
  • Brazilian Society of Hypertension
  • Congenital Heart Surgeons Society
  • Congenital Cardiac Anesthesia Society
  • Society for Cardiovascular Angiography and Interventions Foundation
  • Vascular and Endovascular Surgery Society

Europe

  • European Society of Cardiology
  • British Cardiovascular Society
  • British Heart Foundation
  • British Hypertension Society
  • British Heart Failure Society
  • French Society of Cardiology
  • German Cardiac Society
  • German Heart Foundation
  • Spanish Society of Cardiology
  • Swiss Society of Cardiology
  • Swedish Society of Cardiology
  • Irish Cardiac Society
  • Polish Cardiac Society
  • Portuguese Society of Cardiology
  • Austrian Society of Cardiology
  • Belgian Society of Cardiology
  • Danish Society of Cardiology
  • Finnish Cardiac Society
  • Norwegian Society of Cardiology
  • European Society for Vascular Surgery
  • European Society of Heart and Lung Transplantation
  • World Heart Federation
  • Zurich Heart House

Middle East and Eurasia

  • Saudi Heart Association
  • Emirates Cardiac Society
  • Gulf Heart Association
  • Iranian Heart Association
  • Russian Society of Cardiology
  • Russian Cardiac Society
  • Ukrainian Association of Cardiology
  • Armenian Cardiologists Association
  • Algerian Society of Hypertension

Asia-Pacific and Global

  • Asian Pacific Society of Cardiology
  • Asian Pacific Society of Hypertension
  • Cardiological Society of India
  • Chinese Society of Cardiology
  • Korean Society of Cardiology
  • Cardiac Society of Australia and New Zealand
  • Singapore Cardiac Society
  • National Heart Association of Malaysia
  • Philippine Heart Association
  • Taiwan Society of Cardiology
  • Hong Kong College of Cardiology
  • Indonesian Heart Association
  • Vietnam Heart Association
  • Pan-African Society of Cardiology
  • World Health Organization

Participants and Participation Options

Speaker
Deliver keynote or invited lectures and share cutting-edge research, clinical innovations, and expert insights with a global audience of cardiovascular professionals.

Delegate
Attend scientific sessions, panel discussions, and networking events, with full access to conference materials and opportunities to interact with experts across the field of cardiology.

Poster Presenter
Showcase original cardiovascular research through printed or digital poster presentations and engage in direct discussions with attendees, researchers, and clinical experts.

Exhibitor
Display cardiovascular products, technologies, devices, or services in dedicated exhibition spaces and connect with delegates, industry leaders, potential clients, and collaborators.

Video Presentation
Present research findings, clinical experiences, or innovations through recorded video sessions, ideal for participants unable to attend the congress in person.

E-Poster Presenter
Share research electronically via interactive electronic posters and participate in virtual discussions and question-and-answer sessions with global attendees.

Virtual Registration
Attend live-streamed keynote lectures, scientific presentations, and panel discussions online, with access to conference recordings, digital materials, and virtual networking opportunities. This option is ideal for international participants or those unable to travel.

Participant Benefits

Earn Continuing Medical Education and Continuing Professional Development points
Networking opportunities with global cardiology experts and peers
Certificate of participation
Digital Object Identifier publication opportunities in conference proceedings
Access to cutting-edge cardiovascular research and clinical advancements
Enhanced professional visibility for speakers, presenters, and exhibitors
Opportunities for global collaboration and academic exchange

Abstract Submission and Registration Timeline

Abstract Submission Open: Now Open
Early Bird Registration Deadline: January 06, 2026
Standard Registration Deadline: February 06, 2026
Final Registration Deadline: April 06, 2026

Abstract Submission Details

All submitted abstracts will undergo a peer-review process to ensure scientific quality and relevance to cardiovascular medicine. Authors of accepted abstracts will receive an official Abstract Acceptance Letter confirming inclusion in the Heart Congress 2026 scientific program. Accepted abstracts will be published in the conference proceedings with a Digital Object Identifier, ensuring global visibility and citation opportunities.

For Inquiries

For questions or assistance regarding Heart Congress 2026, abstract submission, registration, or participation, please contact:

Email: contact@speakermeeting.com
Phone: +44 2880 090005
Website: https://heartcongress.healthconferences.org/

You may also connect with us through our social media channels for updates, announcements, and support.

Past Conference Report

HEART CONGRESS 2025

We are delighted to welcome you to the 39th World Congress on Heart Diseases, scheduled to be held on October 20-21, 2025, in Frankfurt, Germany. This prestigious global event will bring together leading cardiologists, researchers, healthcare professionals, and industry experts to explore the latest advancements in cardiovascular medicine under the theme: "Transforming Cardiovascular Health Through Innovative Research and Advanced Technology.

As heart diseases continue to be the leading cause of mortality worldwide, this congress provides a dynamic platform to discuss groundbreaking research, emerging technologies, clinical practices, and innovative strategies aimed at improving cardiovascular outcomes. Through keynote sessions, expert panels, interactive workshops, and poster presentations, participants will engage in high-level discussions and networking opportunities that foster collaboration and knowledge sharing across disciplines.

Join us in Frankfurt—a city known for its scientific spirit and rich culture—for two days of inspiring science, meaningful collaboration, and a shared commitment to advancing global heart health. The city is home to world-class research institutions, making it an ideal setting for a cutting-edge scientific congress. Visitors can enjoy the scenic beauty of the River Main, explore the historic Römer square, and experience vibrant German hospitality. With its excellent connectivity, state-of-the-art conference venues, and rich cultural offerings, Frankfurt provides the perfect backdrop for a truly memorable and impactful event.


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date April 06-07, 2026

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Supported By

Interventional Cardiology Cardiovascular Diseases & Diagnosis Cardiovascular Investigations: Open Access

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by